Adaptive Biotechnologies Corp
ADPT
58 insider filings · Latest: Aug 10, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Mar 6 1:05 AM | Michelle Renee GriffinDirector | Sale | 48,044 | $15.30 | $735.1K | 15,394(D) | View → |
| Mar 5, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Sale | 30,941 | $16.00 | $495.1K | 575,235(D) | View → |
| Mar 4, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Sale | 30,941 | $16.60 | $513.6K | 579,573(D) | View → |
| Mar 3, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Sale | 30,941 | $15.67 | $484.8K | 583,911(D) | View → |
| Mar 3, 2026 | Mar 5 12:58 AM | Harlan S RobinsChief Scientific Officer | Sale | 14,233 | $16.52 | $235.1K | 1,155,291(D) | View → |
| Mar 2, 2026 | Mar 5 12:58 AM | Harlan S RobinsChief Scientific Officer | Sale | 10,000 | $15.72 | $157.2K | 1,169,524(D) | View → |
| Mar 3, 2026 | Mar 4 12:51 AM | Chad M RobinsDirector, CEO and Chairman | Sale | 53,083 | $15.52 | $823.8K | 1,934,247(D) | View → |
| Mar 2, 2026 | Mar 4 12:51 AM | Chad M RobinsDirector, CEO and Chairman | Sale | 289,024 | $15.82 | $4.6M | 1,987,330(D) | View → |
| Feb 27, 2026 | Mar 4 12:51 AM | Chad M RobinsDirector, CEO and Chairman | Sale | 182,891 | $15.99 | $2.9M | 2,276,354(D) | View → |
| Mar 3, 2026 | Mar 3 9:59 PM | Harlan Robins | Proposed Sale | 14,233 | $16.08 | $228.9K | — | View → |
| Mar 3, 2026 | Mar 3 9:59 PM | Chad Robins | Proposed Sale | 53,083 | $16.08 | $853.6K | — | View → |
| Mar 3, 2026 | Mar 3 9:50 PM | JULIE RUBINSTEIN | Proposed Sale | 1,206,661 | $16.12 | $19.5M | — | View → |
| Mar 3, 2026 | Mar 3 9:50 PM | MICHELLE GRIFFIN | Proposed Sale | 48,044 | $16.12 | $774.5K | — | View → |
| Mar 2, 2026 | Mar 2 10:24 PM | Harlan Robins | Proposed Sale | 10,000 | $16.12 | $161.2K | — | View → |
| Mar 2, 2026 | Mar 2 10:24 PM | Chad Robins | Proposed Sale | 289,024 | $16.12 | $4.7M | — | View → |
| Feb 27, 2026 | Feb 27 9:47 PM | Chad Robins | Proposed Sale | 182,891 | $16.02 | $2.9M | — | View → |
| Feb 4, 2026 | Feb 7 12:30 AM | Kyle PiskelChief Financial Officer | Sale | 2,145 | $18.46 | $39.6K | 216,637(D) | View → |
| Feb 3, 2026 | Feb 5 12:48 AM | Harlan S RobinsChief Scientific Officer | Sale | 8,120 | $19.00 | $154.3K | 1,179,524(D) | View → |
| Feb 2, 2026 | Feb 5 12:48 AM | Harlan S RobinsChief Scientific Officer | Sale | 34,668 | $18.60 | $644.8K | 1,187,644(D) | View → |
| Feb 2, 2026 | Feb 5 12:37 AM | Chad M RobinsDirector, CEO and Chairman | Sale | 124,998 | $18.44 | $2.3M | 2,459,245(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 21, 2026 | Jul 23 11:34 PM | Harlan S RobinsChief Scientific Officer | Option Exercise | 284,800 | $6.55 | 0(D) | View → |
| Jul 15, 2026 | Jul 17 11:23 PM | Francis LOChief People Officer | Option Exercise | 105,762 | $12.14 | 37,511(D) | View → |
| Jul 2, 2026 | Jul 6 11:19 PM | Francis LOChief People Officer | Option Exercise | 37,863 | $12.14 | 60,222(D) | View → |
| Jul 1, 2026 | Jul 6 11:19 PM | Francis LOChief People Officer | Option Exercise | 37,758 | $12.14 | 126,584(D) | View → |
| Jun 29, 2026 | Jun 30 11:25 PM | Sharon BenzenoChief Commercial Ofc Imm Med | Option Exercise | 103,295 | $12.14 | 113,457(D) | View → |
| Jun 26, 2026 | Jun 30 11:25 PM | Sharon BenzenoChief Commercial Ofc Imm Med | Option Exercise | 11,034 | $12.14 | 1,837(D) | View → |
| Jun 25, 2026 | Jun 29 11:49 PM | Michelle Renee GriffinDirector | Option Exercise | 52,084 | $7.80 | 0(D) | View → |
| Jun 4, 2026 | Jun 9 12:29 AM | Francis LOChief People Officer | Option Exercise | 19,521 | $12.14 | 140,648(D) | View → |
| Apr 27, 2026 | Apr 29 11:08 PM | Julie RubinsteinPresident and COO | Option Exercise | 14,707 | $8.46 | 45,731(D) | View → |
| Apr 24, 2026 | Apr 24 10:29 PM | Julie RubinsteinPresident and COO | Option Exercise | 14,722 | $8.46 | 60,438(D) | View → |
| Apr 23, 2026 | Apr 24 10:29 PM | Julie RubinsteinPresident and COO | Option Exercise | 14,722 | $8.46 | 75,160(D) | View → |
| Apr 22, 2026 | Apr 24 10:29 PM | Julie RubinsteinPresident and COO | Option Exercise | 14,722 | $8.46 | 89,882(D) | View → |
| Apr 21, 2026 | Apr 21 10:07 PM | Julie RubinsteinPresident and COO | Option Exercise | 26,603 | $12.14 | 379,777(D) | View → |
| Apr 20, 2026 | Apr 21 10:07 PM | Julie RubinsteinPresident and COO | Option Exercise | 14,722 | $8.46 | 119,326(D) | View → |
| Apr 17, 2026 | Apr 21 10:07 PM | Julie RubinsteinPresident and COO | Option Exercise | 14,722 | $8.46 | 134,048(D) | View → |
| Apr 16, 2026 | Apr 16 11:36 PM | Julie RubinsteinPresident and COO | Option Exercise | 14,722 | $8.46 | 148,770(D) | View → |
| Apr 15, 2026 | Apr 16 11:36 PM | Julie RubinsteinPresident and COO | Option Exercise | 14,722 | $8.46 | 163,492(D) | View → |
| Apr 14, 2026 | Apr 16 11:36 PM | Julie RubinsteinPresident and COO | Option Exercise | 14,722 | $8.46 | 178,214(D) | View → |
| Apr 13, 2026 | Apr 13 11:44 PM | Julie RubinsteinPresident and COO | Option Exercise | 14,722 | $8.46 | 192,936(D) | View → |
| Apr 10, 2026 | Apr 13 11:44 PM | Julie RubinsteinPresident and COO | Option Exercise | 14,722 | $7.27 | 8,109(D) | View → |
Page 1 of 3
Next →